Papers
1
Total Citations
3
H-Index
1
About
Galen Conti is a urologic oncology researcher whose work focuses on optimizing treatment outcomes for prostate cancer patients, particularly through comparative effectiveness research. His major contributions center on evaluating quality of life (QoL) differences between surgical approaches for localized prostate cancer. Conti’s most cited study, a 2022 prospective analysis of men choosing open versus robotic radical prostatectomy, draws from a racially diverse multi-institutional database to provide long-term QoL results—a critical gap in the literature. This work highlights his commitment to patient-centered outcomes and health equity, as it includes underrepresented populations often excluded from surgical trials. While his citation count (3 for this paper) reflects a nascent career, the study’s design and focus on real-world, diverse cohorts signal its potential for future impact. Conti’s research bridges surgical innovation and patient experience, offering actionable insights for shared decision-making. His attention to longitudinal, multi-institutional data positions him as a rising voice in evidence-based urologic care, particularly for men navigating treatment choices.
Research Focus
Key Achievements
Top Papers
- 1